$辉瑞(PFE)$  Pfizer (PFE) has an average rating of overweight and mean price target of $28.64, according to analysts polled by FactSet.

$特斯拉(TSLA)$  June 5 - Prominent investor Ron Baron has come out in support of Tesla CEO Elon Musk's $56 billion pay package, which is up for a shareholder vote next week, according to an open letter from the Baron Capital founder on Tuesday.

$辉瑞(PFE)$  C.Q. Pharmaceutical's (SHE:000950) unit, Chongqing Yaoyou Pharmaceutical, granted Pfizer exclusive rights to develop, produce and market oral small molecule glucagon-like peptide-1 receptor agonists and products containing this active ingredient, such as YP05002, according to a Shenzhen bourse filing on Thursday.

$比亚迪(002594)$  BYD (HKG:1211, SHE:002594) sold 382,585 vehicles in June, up from 341,658 units a year earlier, a Tuesday filing with the Hong Kong bourse said.

$英伟达(NVDA)$  Asian Citrus (HKG:0073) said it sold 800 Nvidia shares through its wholly owned unit Cheer Kind at an average price of $181.61 each, raising about $145,000, according to a Thursday Hong Kong bourse filing.

$辉瑞(PFE)$  Pfizer (PFE) said Tuesday that its experimental breast cancer drug atirmociclib has met the primary endpoint in a mid-stage study of patients with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer who had previously received CDK4/6 inhibitor treatment.

$纳斯达克(.IXIC)$  That's the message from two days of solid earnings from some of the biggest names in U.S. finance. Early Thursday, both Bank of America and Morgan Stanley said profit more than doubled last quarter, boosted by Wall Street businesses. That followed strong results from their major peers a day earlier.

$纳斯达克(.IXIC)$  Ulta Beauty (NASDAQ:ULTA) customers can now order their favorite cosmetics, skincare and haircare products directly from the DoorDash (NASDAQ:DASH) app thanks to an extended partnership between the two companies.

$辉瑞(PFE)$  Pfizer (PFE) and Valneva (VALN) said Monday that their investigational vaccine candidate LB6V against outdoor Lyme disease reduced the rate of confirmed cases by 73.2% compared with placebo in a phase 3 clinical study.